Related Experiment Video
Updated: Aug 8, 2026

Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets
Published on: July 8, 2010
Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein
Y W Kim1, G A Otterson, R A Kratzke
1NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Abstract:
The growth suppressor activities of the RB and p107 products are believed to be mediated by the reversible binding of a heterogeneous family of cellular proteins to a conserved T/E1A pocket domain that is present within both proteins. To study the functional role of these interactions, we examined the properties of cellular retinoblastoma binding protein 2 (RBP2) binding to RB, p107, and the related TATA-binding protein (TBP) product. We observed that although RBP2 bound exclusively to the T/E1A pocket of p107, it could interact with RB through independent T/E1A and non-T/E1A domains and with TBP only through the non-T/E1A domain. Consistent with this observation, we found that a mutation within the Leu-X-Cys-X-Glu motif of RBP2 resulted in loss of ability to precipitate p107, while RB- and TBP-binding activities were retained. We located the non-T/E1A binding site of RBP2 on a 15-kDa fragment that is independent from the Leu-X-Cys-X-Glu motif and encodes binding activity for RB and TBP but does not interact with p107. Despite the presence of a non-T/E1A binding site, however, recombinant RBP2 retained the ability to preferentially precipitate active hypophosphorylated RB from whole-cell lysates. In addition, we found that cotransfection of RBP2 can reverse in vivo RB-mediated suppression of E2F activity. These findings confirm the differential binding specificities of the related RB, p107, and TBP proteins and support the presence of multifunctional domains on the nuclear RBP2 product which may allow complex interactions with the cellular transcription machinery.
Insights
Retinoblastoma-binding protein 2 (RBP2) exhibits differential binding to RB, p107, and TBP proteins, with distinct domains mediating these interactions. This specificity influences RBP2
Area of Science:
- Molecular Biology
- Cell Biology
- Protein-protein Interactions
Background:
- The growth suppressor functions of retinoblastoma (RB) and p107 proteins are mediated by interactions with cellular proteins binding to their T/E1A pocket domain.
- Understanding these interactions is crucial for elucidating cellular growth regulation and transcription machinery.
Purpose of the Study:
- To investigate the binding properties of cellular retinoblastoma-binding protein 2 (RBP2) to RB, p107, and TATA-binding protein (TBP).
- To determine the functional role of specific domains within RBP2 in mediating these interactions.
Main Methods:
- Examination of RBP2 binding to RB, p107, and TBP using co-precipitation assays.
- Analysis of RBP2 mutants, including a mutation in the Leu-X-Cys-X-Glu motif.
- Identification of RBP2 binding sites through fragmentation and recombinant protein analysis.
- Assessment of RBP2's effect on RB-mediated suppression of E2F activity in vivo.
Main Results:
- RBP2 binds exclusively to the T/E1A pocket of p107.
- RBP2 interacts with RB via both T/E1A and non-T/E1A domains, and with TBP solely through a non-T/E1A domain.
- A mutation in RBP2's Leu-X-Cys-X-Glu motif abolished p107 binding but retained RB and TBP binding.
- A distinct 15-kDa fragment of RBP2 mediates RB and TBP binding but not p107 binding.
- Recombinant RBP2 preferentially precipitates active hypophosphorylated RB.
- RBP2 cotransfection reverses RB-mediated suppression of E2F activity in vivo.
Conclusions:
- RBP2 displays differential binding specificities towards RB, p107, and TBP.
- RBP2 possesses multifunctional domains enabling complex interactions with the cellular transcription machinery.
- These findings highlight the intricate regulation of cellular processes by protein-protein interactions involving RB family proteins.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

